A novel extended sequence learning task (ESLeT) for rodents: validation and the effects of amphetamine, scopolamine and striatal lesions.
Neurodegenerative diseases of the basal ganglia have been associated with impairments in 'implicit learning', failing to detect repeated sequences embedded in long series of random stimuli. The present study has introduced a novel 5-step sequence learning task (ESLeT) for rats, in which the animals learn to respond to randomly occurring stimuli in a horizontal spatial array, and to chain 5 sequential stimulus-response choices to gain food reward. The rats exhibit improved performance in both speed and accuracy of responding when the sequence is predictable following the first stimulus in the chain, suggesting a comparable capacity for 'implicit learning'. Performance was more rapid but less accurate when the rats were pre-treated with the dopamine indirect agonist amphetamine, markedly disrupted in both dependent variables when pre-treated with the cholinergic antagonist, scopolamine, and modestly disrupted following bilateral striatal lesions, with distinctive patterns of error and changes in the precise patterns of stimulus-by-stimulus responding associated with each experimental treatment. The ESLeT task provides a new test with distinctive advantages for the analysis of vigilance, serial responding and procedural motor learning in animal models of human neurodegenerative disease.
Dunnett
Stephen B
SB
School of Biosciences, Cardiff University, Wales, UK. dunnett@cf.ac.uk
Fuller
Anna
A
Rosser
Anne E
AE
Brooks
Simon P
SP
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001288:Attention / Q000187:drug effects / Q000502:physiology; D018680:Cholinergic Antagonists / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects* / Q000502:physiology; D015259:Dopamine Agents / Q000494:pharmacology*; D008297:Male; D009483:Neuropsychological Tests; D011897:Random Allocation; D051381:Rats; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D012201:Reward; D012601:Scopolamine / Q000494:pharmacology*; D012691:Serial Learning / Q000187:drug effects* / Q000502:physiology
D018680:Cholinergic Antagonists; D015259:Dopamine Agents; D000661:Amphetamine; D012601:Scopolamine